Trial ID or NCT#
Dystrophic epidermolysis bullosa (DEB) is a group of diseases caused by genetic mutations in the gene for type VII collagen. DEB can be severe or mild with the recessive disease usually being more severe. Patients with DEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening subjects with DEB to evaluate characteristics of the subjects and their cells in order to develop new strategies of therapy.
Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa
Contact us to find out if this trial is right for you.
Kylie Loutit, BS